baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

ATAI Life Sciences NV/ NL0015000DX5 /

2024-05-03 10:00:00 PM	Chg. -0.0800	Volume	Bid11:46:03 AM	Ask11:46:03 AM	High	Low
2.0500USD	-3.76%	1.18 mill. Turnover: 2.35 mill.	2.0500Bid Size: 100	2.2100Ask Size: 4,400	2.2850	2.0200

GlobeNewswire 04-24 atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study E...

GlobeNewswire 04-17 atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Jo...

GlobeNewswire 03-28 atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporat...

GlobeNewswire 03-27 atai Life Sciences Announces Positive Initial Results from Beckley Psytech’s Phase 2a Open Label Stu...

GlobeNewswire 03-21 IntelGenx Reports Fourth Quarter and Full-Year 2023 Financial Results

GlobeNewswire 03-11 IntelGenx Enters Into a Third Amended and Restated Loan Agreement With atai Life Sciences

GlobeNewswire 03-04 atai Life Sciences Announces First Participant Dosed in Phase 1b Trial of VLS-01

GlobeNewswire 02-28 atai Life Sciences to Participate in the Upcoming TD Cowen 44th Annual Health Care Conference

GlobeNewswire 02-06 atai Life Sciences Appoints Anne Johnson as Chief Financial Officer

GlobeNewswire 01-04 atai Life Sciences Announces Strategic Investment in Beckley Psytech to Accelerate the Clinical Deve...

GlobeNewswire 01-02 atai Life Sciences Announces Positive Topline Results from Single Ascending Dose Phase 1 Study with ...

GlobeNewswire 2023-12-05 IntelGenx Announces Closing of Previously Announced Subsequent Non-Brokered Private Placement With a...

GlobeNewswire 2023-12-04 IntelGenx Announces Changes to its Board of Directors

GlobeNewswire 2023-11-28 IntelGenx Announces Shareholder Approval of Financing Transactions

Newsfile Corp 2023-11-28 Investor Ideas Potcasts: Interview with Kaya Holdings on the Sacred Mushroom Center - Pioneers with ...

GlobeNewswire 2023-11-14 atai Life Sciences Reports Third Quarter 2023 Financial Results and Pipeline Highlights

GlobeNewswire 2023-11-13 IntelGenx Reminds Shareholders to Vote at Upcoming Special Meeting

GlobeNewswire 2023-11-09 IntelGenx Reports Third Quarter 2023 Financial Results

GlobeNewswire 2023-10-06 atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS/Neuro Summit

GlobeNewswire 2023-10-02 atai Life Sciences Announces Completion of Phase 1 Study of VLS-01 in Healthy Participants

GlobeNewswire 2023-09-06 atai Life Sciences to Participate in Upcoming September Investor Conferences

GlobeNewswire 2023-08-31 IntelGenx Announces Closing of First Tranche of Non-Brokered Private Placement From Strategic Partne...

Newsfile Corp 2022-11-05 Microdose Announces The Second Annual Microdose Awards Winners

Newsfile Corp 2022-10-19 Microdose Announces the Latest Round of Keynotes, Celebrity Guests and Featured Speakers for the 2nd...

Newsfile Corp 2022-07-12 Microdose Announces New Featured Speakers for Wonderland Miami 2022

ATAI Life Sciences NV/ NL0015000DX5 /

If you wish to receive reply to your feedback, please provide your email address.